Page last updated: 2024-11-06

prednisolone and Acute Biphenotypic Leukemia

prednisolone has been researched along with Acute Biphenotypic Leukemia in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spijkers-Hagelstein, JA1
Schneider, P1
Pinhanços, SM1
Garrido Castro, P1
Pieters, R1
Stam, RW1
Endo, M1
Kanemaru, M1
Kubo, Y1
Kouda, K1
Sakurai, T1
Iizuka, Y1
Takeuchi, J1
Horikoshi, A1
Ohshima, T1

Other Studies

2 other studies available for prednisolone and Acute Biphenotypic Leukemia

ArticleYear
Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:9

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Dose-Response Relationshi

2014
[DBMP-85 was effective at diagnosis and LVP was effective at relapse in a case of acute mixed leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzyl Compounds; Humans;

1990